Widely-used drug can seriously increase women's odds of living to age 90
Time to re-up that AARP subscription.
A popular prescription drug already in millions of medicine cabinets could be the key to unlocking a longer life for women.
New research published in the Journal of Gerontology: Medical Sciences found that those taking this widely-used diabetes drug had a great shot at making it to the big 9-0.
JackF – stock.adobe.com
No, it's not Ozempic — it's called metformin, and almost 20 million Americans are estimated to be taking it to help manage their Type 2 diabetes.
Like other diabetes drugs, this decades-old, dirt-cheap medication works by decreasing the amount of glucose the body absorbs from food and improves its response to insulin.
Also used to treat Polycystic Ovary Syndrome (PCOS), metformin has often been hailed as a 'wonder drug' due to its other health benefits, including improving fertility in women, aiding in weight management and even reducing the risks of heart disease and certain cancers.
This new study set its sights on promising research indicating it may also have anti-aging effects.
Researchers analyzed the data of 438 postmenopausal women — half of whom were on metformin, the other half of whom took another diabetes drug called sulfonylurea.
Like other diabetes drugs, metformin works by decreasing the amount of glucose the body absorbs from food and improves its response to insulin.
Halfpoint – stock.adobe.com
They found that those in the metformin group had a 30% higher chance of making it to 90 when compared to the sulfonylurea group.
The study has a few limitations, the most notable of which is that it had no control group — meaning none of the participants weren't on diabetes medication — as well as a relatively small sample size.
However, one of its strengths was a follow-up period of 14-15 years, which is much longer than the average randomized controlled trial.
All told, the new study adds to an increasing body of research on the geroscience hypothesis, which posits that 'biological aging is malleable and that slowing biological aging may delay or prevent the onset of multiple age-related diseases and disability,' the researchers wrote.
The new study backs up previous research published last year which showed that metformin can slow aging and also prevent disease in healthy older adults.
'I don't know if metformin increases lifespan in people, but the evidence that exists suggests that it very well might,' Steven Austad, a senior scientific adviser at the American Federation for Aging Research who studies the biology of agin, told NPR.
While scientists figure out how to biohack our systems, this little pill may just propel you into your golden years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Rockefeller Foundation Releases New Polling Data: Majority of Americans Want Food is Medicine Programs
Nearly 80% of Americans think food and nutrition should be covered by insurance to address chronic disease NEW YORK, June 12, 2025 /PRNewswire/ -- New polling data from The Rockefeller Foundation shows that more than four in five adults in the United States – across demographics, income levels, party affiliations, and geographies – support integrating Food is Medicine (FIM) programs into U.S. healthcare. The survey, conducted by Hattaway Communications, highlights high interest but low public awareness of FIM programs, which aim to treat and manage chronic disease by increasing access to nutritious foods. The research underscores the perceived benefits of Food is Medicine programs, with 79% of respondents reporting that FIM programs would personally help them eat better after they received a definition of the intervention. "Americans want nutrition and food solutions to help them eat better, improve their health, and save money," said Dr. Rajiv J. Shah, President of The Rockefeller Foundation. "We know that these programs are effective in helping patients manage diet-related chronic disease and are cost-effective too. Now, it's even clearer that there is a huge opportunity to improve Americans' health outcomes by investing in low-cost, individualized Food is Medicine solutions that are both proven and popular." Chronic diseases, such as diabetes, obesity, and heart disease, impact an estimated 133 million Americans—more than 38% (or one-third) of the total U.S. population—and cost the United States $1.1 trillion per year (equivalent to what the U.S. spends on food itself). The vast majority of chronic conditions are diet-related: In the United States alone, poor diets contribute to 500,000 deaths annually. Modeling on medically tailored meals shows that investing in FIM programs could save an estimated $32.1 billion a year, significantly reducing Americans' healthcare costs. Even still, only 13% of Americans polled said they knew about FIM programs, which include interventions such as medically tailored meals and prescriptions for accessing fruits and vegetables, coupled with nutrition support. When presented with the definition of what they entail, survey respondents (84%) resoundingly supported the efforts. Some of the key findings include: More than 4 in 5 Americans believe U.S. healthcare should offer more food and nutrition programs to treat and manage illnesses. Nearly 9 in 10 patients would prefer to rely more on healthy eating than on medications to manage their conditions. Nearly 4 in 5 Americans think that Food is Medicine programs should be covered by both public and private insurance, including 85% of self-identified Democrats and 78% of Republicans. 84% of respondents believed FIM could help improve the overall quality of health in the United States. 79% of respondents said FIM programs could help them personally. 49% of the American public and 67% of healthcare workers view high costs of nutritious food as the single largest barrier to eating well. "We are seeing a growing awareness of diet-related diseases and their consequences in the U.S.," said Devon Klatell, Vice President for the Food Initiative at The Rockefeller Foundation. "This polling data shows that Americans want more support to eat well and live well. Food is Medicine programs are one tool that health care practitioners and providers must be considering as they work to address chronic disease in America." The Rockefeller Foundation commissioned Hattaway Communications to conduct the survey, which polled respondents across all 50 states between February 28 and March 11, 2025. The survey sampled 2,271 respondents, including 1,135 patients and 399 healthcare workers. The sample was weighted by gender and education to align with the actual proportions within the population and is representative of racial demographics across the U.S. Since 2019, The Rockefeller Foundation has supported Food is Medicine programs and invested in research to improve their effectiveness and understand the benefits and costs. As part of this effort, The Foundation announced its $100 million investment to expand access to Food is Medicine, including supporting vital research like the American Heart Association's Health Care by Food Initiative. The Foundation also initiated partnerships with the U.S. Department of Veterans Affairs and the U.S. Department of Health and Human Services to speed the integration of Food Is Medicine into health systems. In February 2025, The Rockefeller Foundation announced $3.5 million in grant funding to support small and mid-scale U.S. farmers, improve health outcomes for people with chronic disease, mitigate rising health care costs in California, Hawaii, Maryland, Massachusetts, Mississippi, North Carolina, Oregon, Rhode Island, Virginia, and Washington, D.C., and advance state-based efforts to include FIM interventions as a medically covered benefit under Medicaid programs. About The Rockefeller FoundationThe Rockefeller Foundation is a pioneering philanthropy built on collaborative partnerships at the frontiers of science, technology, and innovation that enable individuals, families, and communities to flourish. We make big bets to promote the wellbeing of humanity. Today, we are focused on advancing human opportunity and reversing the climate crisis by transforming systems in food, health, energy, and finance. For more information, sign up for our newsletter at and follow us on X @RockefellerFdn and LinkedIn @the-rockefeller-foundation. Media Contact:Ashley Chang, The Rockefeller Foundation: media@ View original content: SOURCE The Rockefeller Foundation Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Eating this Middle Eastern staple daily can lower your cholesterol: study
Give peas a chance! A little legume widely beloved in the Middle Eastern world can offer massive benefits to your heart, a new study has found. And the best part is that this versatile, beige gem is incredibly affordable and probably already in your pantry. The research — recently presented at the NUTRITION 2025 conference — identified chickpeas as the key to significantly lowering cholesterol and inflammation in people with pre-diabetes. More research would be needed to gain a larger sense of the health benefits, particularly in people who are not prediabetic. The study included only 72 participants and lasted just 12 weeks, and the results were similar to eating white rice. However, the findings align with other research indicating chickpeas lead the way in heart-healthy foods. The hummus veg's high fiber content, particularly soluble fiber, is believed to bind with cholesterol in the digestive system and help flush it out of the body. The fiber also promotes healthy gut bacteria and keeps the bowel moving, while chickpeas' low glycemic index can contribute to better blood sugar levels. Legumes in general can mimic the hunger-killing effects of drugs like Ozempic and Wegovy, thereby promoting weight loss by keeping you fuller for longer. A cup of chickpeas can deliver over 12.5 grams of fiber and nearly 15 grams of plant-based protein — all for under 270 calories. They're also a rich source of iron, potassium and magnesium — essential nutrients that support overall health. The new study found that black beans had a similar effect on heart health, which is no real surprise. A cup of cooked black beans provides about 15 grams of protein and 15 grams of fiber at under 230 calories. They're also rich in antioxidants — particularly anthocyanins, the same compounds that give blueberries their health rap — which help fight inflammation and may reduce the risk of chronic conditions like heart disease and cancer. Plus, black beans boast key nutrients like folate, iron, magnesium and potassium, which support everything from brain function to healthy blood pressure. 'The soluble fiber in these legumes helps to lower cholesterol by reducing how much is absorbed into the bloodstream,' registered dietitian Maddie Gallivan, who was not involved with the new study, told Medical News Today. 'When eaten as part of a diverse, plant-rich diet, beans and chickpeas can support a healthy gut microbiome.'
Yahoo
3 hours ago
- Yahoo
RFK Jr.'s newest CDC vaccine panel includes critics of COVID shots, lockdowns
The Brief U.S. Health Secretary Robert F. Kennedy Jr. has replaced the government's vaccine advisory panel with eight new appointees. The new members include vocal critics of COVID-19 vaccines and pandemic lockdowns, such as Dr. Robert Malone and Dr. Martin Kulldorff. Public health groups have raised concerns that Kennedy's changes could undermine long-standing vaccination policies. NEW YORK - U.S. Health Secretary Robert F. Kennedy Jr. has named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week. His selections include a scientist who researched mRNA vaccine technology and transformed into a conservative darling for his criticisms of COVID-19 vaccines, and a leading critic of pandemic-era lockdowns. RELATED: RFK Jr. ousts entire CDC vaccine panel Kennedy made the announcement in a social media post on Wednesday. The backstory Kennedy's decision to "retire" the previous 17-member panel was widely decried by doctors' groups and public health organizations, who feared the advisers would be replaced by a group aligned with Kennedy's desire to reassess — and possibly end — longstanding vaccination recommendations. Dig deeper The new appointees to the Advisory Committee on Immunization Practices include Dr. Robert Malone, the former mRNA researcher who emerged as a close adviser to Kennedy during the measles outbreak. Malone, who runs a wellness institute and a popular blog, rose to popularity during the COVID-19 pandemic as he relayed conspiracy theories around the outbreak and the vaccines that followed. He has appeared on podcasts and other conservative news outlets where he's promoted unproven and alternative treatments for measles and COVID-19. He has claimed that millions of Americans were hypnotized into taking the COVID-19 shots. He's even suggested that those vaccines cause a form of AIDS. He's downplayed deaths related to one of the largest measles outbreaks in the U.S. in years. Other appointees include Dr. Martin Kulldorff, a biostatistician and epidemiologist who was a co-author of the Great Barrington Declaration, an October 2020 letter maintaining that pandemic shutdowns were causing irreparable harm. Dr. Cody Meissner, a former ACIP member, also was named. Big picture view The committee, created in 1964, makes recommendations to the director of the Centers for Disease Control and Prevention. CDC directors almost always approve those recommendations on how Food and Drug Administration-cleared vaccines should be used. The CDC's final recommendations are widely heeded by doctors and determine the scope of vaccination programs. The Source The Associated Press contributed to this report. The information in this story comes from a social media announcement made by U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday, in which he introduced eight new members to the federal vaccine advisory panel. This story was reported from Los Angeles.
